Global Glycobiology & Glycomics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Glycobiology & Glycomics Market Research Report 2024
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
According to Mr Accuracy reports’s new survey, global Glycobiology & Glycomics market is projected to reach US$ 1421.7 million in 2034, increasing from US$ 1143 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glycobiology & Glycomics market research.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 34%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glycobiology & Glycomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
Agilent Technologies
New England Biolabs
Waters Corp
Bruker Corp
Sigma-Aldrich Corp
Takara Bio
Prozyme
Danaher Corp
Shimadzu Corp
Segment by Type
Eagents
Enzymes
Kits
Instruments
Oncology
Diagnostics
Immunology
Drug Discovery and Development
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glycobiology & Glycomics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
According to Mr Accuracy reports’s new survey, global Glycobiology & Glycomics market is projected to reach US$ 1421.7 million in 2034, increasing from US$ 1143 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glycobiology & Glycomics market research.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 34%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glycobiology & Glycomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Agilent Technologies
New England Biolabs
Waters Corp
Bruker Corp
Sigma-Aldrich Corp
Takara Bio
Prozyme
Danaher Corp
Shimadzu Corp
Segment by Type
Eagents
Enzymes
Kits
Instruments
Segment by Application
Oncology
Diagnostics
Immunology
Drug Discovery and Development
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glycobiology & Glycomics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices